TWD 26.9
(0.94%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 60.62 Million TWD | 10.38% |
2022 | 54.92 Million TWD | 78.55% |
2021 | 30.76 Million TWD | -21.83% |
2020 | 39.35 Million TWD | 23.89% |
2019 | 31.76 Million TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 38.44 Million TWD | -36.59% |
2024 Q2 | 38.44 Million TWD | 0.0% |
2023 FY | 60.62 Million TWD | 10.38% |
2023 Q2 | 38.96 Million TWD | 0.0% |
2023 Q1 | 38.96 Million TWD | -29.06% |
2023 Q4 | 60.62 Million TWD | 0.0% |
2023 Q3 | 60.62 Million TWD | 55.6% |
2022 Q3 | 54.92 Million TWD | 0.0% |
2022 Q4 | 54.92 Million TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Bio Preventive Medicine Corp. | 124.72 Million TWD | 51.395% |
Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 83.541% |
Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -660.474% |
Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 81.543% |
NaviFUS Corp. | 53.4 Million TWD | -13.528% |
G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 49.42% |
Sinew Pharma Inc. | 39.71 Million TWD | -52.654% |
Lin BioScience, Inc. | 167.73 Million TWD | 63.856% |
TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -816.062% |
Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 73.374% |
Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -766.814% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 89.61% |
AP Biosciences Inc | 106.65 Million TWD | 43.155% |
Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 91.729% |
RBC Bioscience Corporation | 513.08 Million TWD | 88.184% |
Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 93.78% |
EirGenix Inc. | 1.14 Billion TWD | 94.706% |
Enimmune corporation | 173.46 Million TWD | 65.05% |
Lukas Biomedical Inc. | 161.05 Million TWD | 62.359% |
BRIM Biotechnology, Inc. | 42.15 Million TWD | -43.804% |
3D Global Biotech Inc. | 30.68 Million TWD | -97.598% |
TaiMed Biologics Inc. | 1.32 Billion TWD | 95.434% |
Mycenax Biotech Inc. | 1.32 Billion TWD | 95.418% |
TCI GENE Inc. | 155.54 Million TWD | 61.025% |
SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -185.617% |
Oneness Biotech Co., Ltd. | 866.42 Million TWD | 93.003% |
Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -553.568% |
Feng Chi Biotech Corp. | 63.03 Million TWD | 3.822% |
NeoCore Technology Co., Ltd. | 197.47 Million TWD | 69.299% |
TWi Biotechnology, Inc. | 55.81 Million TWD | -8.622% |
Neith Corporation | 17.43 Million TWD | -247.76% |
Sunny Pharmtech Inc. | 512.43 Million TWD | 88.169% |
VBI | 21.25 Million TWD | -185.281% |
Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 73.976% |
GeneReach Biotechnology Corp. | 313.7 Million TWD | 80.675% |
Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -160.697% |
CHO Pharma, Inc. | 110.83 Million TWD | 45.3% |
Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -4.456% |
MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -137.671% |
Visgeneer Inc. | 185.6 Million TWD | 67.337% |
Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 83.367% |
BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 45.861% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 87.409% |
Sagittarius Life Science Corp | 137.82 Million TWD | 56.013% |
BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 35.308% |
GlycoNex Incorporation | 276.39 Million TWD | 78.066% |
Medigen Biotechnology Corp. | 3.53 Billion TWD | 98.283% |
Pharmosa Biopharm Inc. | 195.99 Million TWD | 69.067% |
PharmaEngine, Inc. | 91 Million TWD | 33.384% |
Intech Biopharm Corporation | 1.54 Billion TWD | 96.072% |
Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 88.22% |
BiOptic Inc. | 170.56 Million TWD | 64.456% |
TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 45.353% |
Senhwa Biosciences, Inc. | 46.17 Million TWD | -31.294% |
NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | 6.568% |
OBI Pharma, Inc. | 650.44 Million TWD | 90.68% |
Savior Lifetec Corporation | 457.95 Million TWD | 86.762% |
Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -126.103% |
Level Biotechnology Inc. | 273.2 Million TWD | 77.809% |
Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 97.301% |
Meribank Biotech Co., Ltd | 390.81 Million TWD | 84.487% |
Acepodia, Inc. | 384.47 Million TWD | 84.232% |
Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | 29.137% |